PMID: 26126304
Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill?
Correct Answer: no

======================= Launch the MCC process =======================
PMID: 26126304
Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill?

----- GPT's initial response -----
GPT is reasoning the answer...


**1. Question Analysis**
- **Core Content:** The research question aims to determine whether pretreatment with estradiol and a GnRH antagonist (E2 + antag) before administering a microdose leuprolide (ML) protocol improves in vitro fertilization (IVF) outcomes in poor responders, compared to pretreatment with an oral contraceptive pill (OCP).
- **Key Information to Look For:** Comparative IVF outcomes between E2 + antag/ML and OCP/ML groups, including ongoing pregnancy rates, number of oocytes retrieved, cancellation rates, and implantation rates.

**2. Evidence Evaluation**
- **Research Results and Data:** The study found that the OCP/ML group had significantly higher ongoing pregnancy rates (40% vs. 15%) compared to the E2 + antag/ML group. There were trends toward a greater number of oocytes retrieved and improved implantation rates in the OCP/ML group, but these did not reach statistical significance. Additionally, there were no significant differences in gonadotropin requirements, cancellation rates, or the number of embryos transferred between the two groups.
- **Strength and Reliability:** The study was retrospective and included 130 women classified as poor responders. Retrospective studies are generally considered lower in the hierarchy of evidence compared to randomized controlled trials. The abstract also suggests that randomized trials with adequate power are needed, indicating that the current evidence may not be definitive.
- **Relevance:** The evidence directly addresses the research question by comparing the two pretreatment protocols in the specified patient population.

**3. Conclusion**
Based on the available evidence from this retrospective study, pretreatment with E2 + antag does not improve IVF outcomes compared to OCP in poor responders. In fact, ongoing pregnancy rates were significantly higher in the OCP/ML group. However, the study's retrospective nature and the call for randomized trials suggest that while current evidence leans towards "no," further research could provide more definitive answers.

**4. Final Answer:**
**My final choice is: "no"**
GPT selected: no

----- Qwen's initial response -----
Qwen is reasoning the answer...


**1. Question Analysis**  
The question asks whether pretreatment with estradiol + GnRH antagonist improves IVF outcomes (e.g., ongoing pregnancy rates, oocyte retrieval, implantation) in poor responders compared to oral contraceptive pills (OCP) when followed by microdose leuprolide (ML). The key comparison is between the E2+antag/ML and OCP/ML protocols.  

**2. Evidence Evaluation**  
- **Results**: The OCP/ML group had significantly higher ongoing pregnancy rates (40% vs. 15%) and trends toward more oocytes retrieved (7.7 vs. 5.9) and better implantation rates (20% vs. 12%). Cancellation rates and embryo transfers were similar.  
- **Strength/Reliability**: This was a retrospective study of 130 patients, which may have limitations in controlling confounders. However, baseline characteristics were comparable between groups.  
- **Relevance**: The study directly addresses the question by comparing the two pretreatment protocols in poor responders using ML.  

**3. Conclusion**  
The data show that the E2+antag pretreatment group had **worse outcomes** (lower ongoing pregnancy rates) compared to OCP pretreatment. The study explicitly concludes that E2+antag does not improve outcomes over OCP. Thus, the answer is "no."  

**4. Final Answer:**  
**My final choice is: "no"**
Qwen selected: no

----- Deepseek's initial response -----
DeepSeek is reasoning the answer...

**1. Question Analysis**  
The question asks whether luteal estradiol (E2) + GnRH antagonist (E2 + antag) pretreatment improves IVF outcomes compared to oral contraceptive pill (OCP) pretreatment in poor responders using the microdose leuprolide (ML) protocol. Key outcomes include ongoing pregnancy rates, oocyte retrieval numbers, and cancellation rates.

**2. Evidence Evaluation**  
- The retrospective study compared OCP/ML (n=130) and E2+antag/ML groups.  
- **Ongoing pregnancy rates were significantly higher with OCP/ML (40% vs. 15%)**, favoring OCP.  
- Oocyte retrieval (7.7 vs. 5.9) and implantation rates (20% vs. 12%) numerically favored OCP but were not statistically significant.  
- No differences in gonadotropin use, cancellation rates, or embryos transferred.  
- The authors conclude E2+antag does **not** improve outcomes compared to OCP and recommend further randomized trials.  
- Limitations include retrospective design and small sample size, reducing statistical power for some outcomes.  

**3. Conclusion**  
The evidence shows **no benefit** for E2+antag over OCP in ML protocols for poor responders, with OCP demonstrating superior pregnancy rates. While trends in oocyte retrieval/implantation favored OCP, the studyâ€™s design limits definitive conclusions. However, the significant pregnancy rate difference strongly supports "no."  

**4. Final Answer**  
**My final choice is: no**
DeepSeek selected: no

Initial consensus: All models selected no